Ultrasound-induced blood-brain barrier opening

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1332-1345

  Konofagou, Elisa E ^a,b   Tung, Yao Sheng ^a   Choi, James ^a   Deffieux, Thomas ^a   Baseri, Babak ^a   Vlachos, Fotios ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Blood brain barrier; Brain drug delivery; Disruption; Focused ultrasound; Microbubble; Safety

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL EFFECTIVENESS; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; EVOKED OTOACOUSTIC EMISSION; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOLOGY; HUMAN; IN VIVO STUDY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MICROBUBBLE; MICROENVIRONMENT; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; RISK ASSESSMENT;

EID: 84861144207     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624364     Document Type: Article

References (64)

1. Pardridge, W. M. The blood-brain barrier: bottleneck in brain drug development. Neuro Rx., 2005, 2, 3-14.
2. Abbott, N. J.; Ronnback, L.; Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci., 2006, 7, 41-53.
3. Stewart, P. A.; Tuor U. I. Blood-eye barriers in the rat: correlation of ultrastructure with function. J. Comp. Neurol., 1994, 340, 566-576.
4. Pardridge, W. M. Molecular trojan horses for blood-brain barrier drug delivery. Discov. Med., 2006, 6, 4.
5. Bakay, L.; Ballantine, Jr., H. T.; Hueter, T. F.; Sosa D. Ultrasonically produced changes in the blood-brain barrier. AMA Arch. Neurol. Psychiatry, 1956, 76, 457-467.
6. Ballantine, Jr., H. T.; Bell, E.; Manlapaz, J. Progress and problems in the neurological applications of focused ultrasound. J. Neurosurg., 1960, 17, 858-876.
7. Patrick, J.T.; Nolting, M.N.; Goss, S.A.; Dines, K.A.; Clendenon, J. L.; Rea, M.A.; Heimburger, R. F. Ultrasound and the blood-brain barrier. Adv. Exp. Med. Biol., 1990, 267, 369-381.
8. Vykhodtseva, N. I.; Hynynen, K.; Damianou, C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo, Ultrasound Med. Biol., 1995, 21, 969-979.
9. Mesiwala, A.H.; Farrell, L.; Wenzel, H.J.; Silbergeld, D.L.; Crum, L.A.; Winn, H.R.; Mourad, P. D. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo, Ultrasound Med. Biol., 2002, 28, 389-400.
10. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Jolesz, F. A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits, Radiology, 2001, 220, 640-646.
11. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Jolesz, F. A. Noninvasive opening of BBB by focused ultrasound, Acta Neurochir. Suppl., 2003, 86, 555-558.
12. McDannold, N.; King, R. L.; Hynynen K. MRI monitoring of heating produced by ultrasound absorption in the skull: in vivo study in pigs. Magn. Reson Med., 2004, 51, 1061-1065.
13. Sheikov, N.; McDannold, N.; Vykhodtseva, N.; Jolesz, F.; Hynynen, K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med. Biol., 2004, 30, 979-989.
14. Hynynen, K.; McDannold, N.; Sheikov, N. A.; Jolesz, F. A.; Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for transskull sonications. Neuroimage, 2005, 24, 12-20.
15. McDannold, N.; Vykhodtseva, N.; Raymond, S.; Jolesz, F. A.; Hynynen, K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med. Biol., 2005, 31, 1527-1537.
16. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Raymond, S.; Weissleder, R.; Jolesz, F. A.; Sheikov, N. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J. Neurosurg., 2006, 105, 445-454.
17. McDannold, N.; Vykhodtseva, N.; Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol., 2006, 51, 793-807.
18. Sheikov, N.; McDannold, N.; Jolesz, F.; Zhang, Y. Z.; Tam, K.; Hynynen, K. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med. Biol., 2006, 32, 1399-1409.
19. Choi, J. J.; Pernot, M.; Small, S.; Konofagou, E. E. Feasibility of transcranial, localized drug-delivery in the brain of Alzheimer'smodel mice using focused ultrasound. IEEE Int. Ultrasonics Symposium Proceedings, 2005, pp. 988-991.
20. Choi, J. J.; Pernot, M.; Small, S.; Konofagou, E. E. Noninvasive Blood-Brain Barrier Opening in Live Mice. AIP Conference Proceedings, 829, 2006, pp. 271-275.
21. Choi, J. J.; Pernot, M.; Brown, T. R.; Small, S. A.; Konofagou, E. E.; Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys. Med. Biol., 2007, 52, 5509-5530.
22. Choi, J. J.; Pernot, M.; Small, S. A.; Konofagou, E. E. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med. Biol., 2007, 33, 95-104.
23. Konofagou, E. E.; Choi, J.J.; Baseri, B.; Lee A. Characterization and Optimization of Trans-Blood-Brain Barrier Diffusion In Vivo, Proceedings of the 8th International Symposium on Therapeutic Ultrasound, Minneapolis, MN, USA, 2009, pp. 418-422.
24. Choi, J. J.; Wang, S.; Brown, T. R.; Small, S. A.; Duff, K. E.; Konofagou, E. E. Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound. Ultrason Imaging, 2008, 30, 189-200.
25. Konofagou, E.E.; Choi J. J. Ultrasound-induced treatment of neurodegenerative diseases across the blood-brain barrier In: Biomedical Applications of Vibration and Acoustics in Therapy. Bioeffects and modelling, Al-Jumaily A.; Fatemi, M. Eds.; ASME Press, New York, NY, 2008; pp. 63-80.
26. Choi, J. J., Wang, S., Tung, Y.-S., Morrison III, B. and Konofagou, E. E. Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med. Biol., 2010,36 (1), 58-67.
27. Baseri, B.; Choi, J. J.; Tung, Y. S.; Konofagou E. E. Safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultras. Med. Biol., 36(9), 2010, 1445-1459.
28. Kaufmann B. A.; Wei K.; Lindner J. R. Contrast echocardiography. Curr. Probl. Cardiol., 2007, 32, 51-96.
29. Christensen D. A. Ultrasonic Bioinstrumentation. New York: John Wiley & Sons, 1988.
30. Miller, D. L. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog. Biophys. Mol. Biol., 2007, 93, 314-330.
31. Chen S.; Kroll, MH.; Shohet, RV.; Frenkel, P.; Mayer, SA.; Grayburn, PA. Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiagraphy, 2002 19, 495-500.
32. Li, P.; Armstrong, WF.; Miller, DL. Impact of myocardial contrast echocardiography on vascular permeability: Comparison of three different contrast agents. Ultrasound Med. Biol., 2004, 30, 83-91.
33. Li, P.; Cao, LQ.; Dou, CY.; Armstrong, WF.; Miller, D. Impact of myocardial contrast echocardiography on vascular permeability: An in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med. Biol., 2003, 29, 1341-1439.
34. Kaps, M.; Seidel, G.; Algermissen, C.; Gerriets, T.; Broillet, A. Pharmacokinetics of echocontrast agent infusion in a dog model. J. Neuroimag., 2001, 11, 298-302.
35. Liu, P.; Gao, Y.; Tan, K.; Zhu, X.; Liu, Z.; Li, P.; Narula, J.; Vannan, M.A. Impact of Microbubble enhanced Ultrasound on Blood-Brain Barrier Permeability: An in vivo dose response study of ultrasound intensity and contrast dose. Circulation, 2005, 112, U602-U605.
36. Yang, F. Y.; Fu, W. M.; Yang, R. S.; Liou, H. C.; Kang, K. H.; W. L. Lin. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med. Biol., 2007, 33, 1421-1427.
37. Miller, D.; Li, P.; Dou, C.; Gordon, D.; Edwards, C.A.; Armstrong, W.F. Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology, 2005, 237, 137-143.
38. Christiansen, J.; French, B.A.; Klibanov, A.L.; Kaul, S.; Lindner, J.R. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med. Biol., 2003, 29, 1759-1767.
39. Chomas, J. E.; Dayton, P.; May, D.; Ferrara, K. Threshold of fragmentation for ultrasonic contrast agents. J. Biomed. Opt., 2001, 6, 141-150.
40. Borden, M.; Kruse, D.; Caskey, C.F.; Zhao, S.; Dayton, P.A.; Ferrara, K.W. Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction. IEEE Trans Ultrason Ferroelecter. Freq. Control., 2005, 52, 1992-2002.
41. Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci., 2004, 5, 347-360.
42. Ghose, A.; Viswanadhan, V.N.; Wendoloski, J.J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem., 1999, 1, 55-68.
43. Lipinski, C. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods, 2000, 44, 235-249.
44. Fischer, H.; Gottschlich, R.; Seelig, A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol., 1998, 165, 201-211.
45. Blasberg, R.; Patlak, C; Fenstermacher, J. D. "Intrathecal chemotherapy brain tissue profiles after ventriculocisternal perfusion". J. Pharmacol. Exp. Ther., 1975, 195, 73-83.
46. Fung, L.; Shin, M.; Tyler, B.; Brem, H.; Saltzman, W.M. Chemotherapeutic drugs released from polymers distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm. Res., 1996, 13, 671-682.
47. Pardridge, W. M. Drug targeting to the brain. Pharm. Res., 2007, 24, 1733-1744.
48. Neppiras, E. A. Acoustic cavitation. Phys. Rep., 1980, 61, 159-251.
49. Leighton, T. The Acoustic Bubble, 1994, First ed. London: Academic.
50. Choi, J. J.; Feshitan, J. A.; Wang, S.; Tung, Y.-S.; Baseri, B.; Borden, M. A.; Konofagou, E. E. The Dependence of the Ultrasound-Induced Blood-Brain Barrier Opening Characteristics on Microbubble Size In Vivo, Proceedings of the 8 th International Symposium on Therapeutic Ultrasound, Minneapolis, MN, USA, 2009, pp. 58-62.
51. Choi, J J.; Small, S. A.; Konofagou, E. E. Optimization of Blood-Brain Barrier Opening in Mice using Focused Ultrasound. IEEE Int. Ultrasonics symposium Proceedings,2006, pp. 540-543.
52. Choi, J.J.; Wang, S.; Morrison III, B.; Konofagou, E. E. Molecular Delivery and Microbubble Dependence Study of the FUS-induced Blood-Brain Barrier Opening In Vivo. EEE Int. Ultrasonics Symposium Proceedings. 2007, pp., 1192-1195.
53. Kinoshita, M.; McDannold, N.; Jolesz, F. A.; Hynynen, K. Noninvasive localized delivery of Herceptin to the mouse brain by MRIguided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl. Acad. Sci. USA, 2006, 103, 11719-11723.
54. Raymond, S. B.; Treat, L. H.; Dewey, J. D.; McDannold, N. J.; Hynynen K.; Bacskai B. J. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models. PLoS ONE, 2008,3, e2175.
55. Sheikov, N.; McDannold, N.; Sharma, S.; Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol., 2008, 34(7), 1093-1104.
56. Treat, L. H.; McDannold, N.; Vykhodtseva, N.; Zhang, Y.; Tam, K.; Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J. Cancer, 2007, 121, 901-907.
57. Feshitan, J. A.; Chen, C. C.; Kwan, J. J.; Borden M. A. Microbubble size isolation by differential centrifugation. J. Colloid Interface Sci., 2009, 329, 316-324.
58. Choi, J.J.; Selert, K.; Konofagou, E.E. Enhanced brain molecular delivery using focused ultrasound at short pulse lengths and low acoustic pressures. IEEE International Ultrasonics Symposium Proceedings, 2010, 1518-1521.
59. Farny, C. H.; Holt, R. G.; Roy, R. A. Temporal and spatial detection of HIFU-induced inertial and hot-vapor cavitation with a diagnostic ultrasound system. Ultrasound Med. Biol., 2009, 35, 603-615.
60. Tung Y., Choi J., Baseri B. and Konofagou E.E., Identifying the Inertial Cavitation Threshold and Skull Effects in a Vessel Phantom Using Focused Ultrasound and Microbubbles, Ultras. Med. Biol., 2010, 36(5), 840-852.
61. Vlachos, F.; Tung, Y.S.; Konofagou, E.E. Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI. Phys. Med. Biol., 2010, 55, 5451-5466.
62. Deffieux, T.; Konofagou, E.E. Numerical study and experimental validation of a simple transcranial focused ultrasound system applied to blood-brain barrier opening. IEEE Ultras. Ferroelectr. Freq. Control, 2010, 57(12), 2637-2653.
63. Baseri B.; Choi J.J.; Deffieux T.; Samiotaki G.; Tung YS.; Olumolade O.; Small, S.A.; Morrison B. III; Konofagou E.E., Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles, Phys. Med. Biol., 2012, 57, N65-N81.
64. Tung, Y-S, Vlachos F., Feshitan J., Borden M.A., Konofagou E.E. the Mechanism of the interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice, J. Acous. Soc. Amer., 2011, 108(40), 130 (5), 3059-3067.